cannabis indica

Índice completo — página 31 de 77

Estudos 3.001 a 3.100 de 7.640, ordenados do mais recente ao mais antigo — nesta página, publicações de 2020. Para buscar por termo ou combinar filtros, use o acervo com busca.

Estudos 3.001 a 3.100

  1. 2020

    Cannabidiol (CBD) as a Promising Anti-Cancer Drug

    FavorávelMetanáliseCâncer
  2. 2020

    Cannabidiol (CBD) as a treatment of acute and chronic back pain: A case series and literature review

    FavorávelMetanáliseDorDor — CrônicaDor — Aguda
  3. 2020

    Cannabidiol (CBD) but not tetrahydrocannabinol (THC) dysregulate in vitro decidualization of human endometrial stromal cells by disruption of estrogen signaling

    DesfavorávelEstudo LaboratorialGestação
  4. 2020

    Cannabidiol (CBD) Consumption and Perceived Impact on Extrahepatic Symptoms in Patients with Autoimmune Hepatitis

    FavorávelMetanáliseHepatite
  5. 2020

    Cannabidiol (CBD) Inhibited Rhodamine-123 Efflux in Cultured Vascular Endothelial Cells and Astrocytes Under Hypoxic Conditions

    FavorávelEstudo LaboratorialEpilepsiaEstresse Oxidativo
  6. 2020

    Cannabidiol (CBD) reduces cocaine-environment memory in mice

    FavorávelEstudo em AnimaisDependência QuímicaDependência — Cocaína
  7. 2020

    Cannabidiol (CBD): a killer for inflammatory rheumatoid arthritis synovial fibroblasts

    FavorávelEstudo LaboratorialArtriteArtrite — Reumatoide
  8. 2020

    Cannabidiol alleviates hemorrhagic shock-induced neural apoptosis in rats by inducing autophagy through activation of the PI3K/AKT pathway

    FavorávelEstudo em AnimaisDoenças Cardiovasculares (DCV)AVCLesão de Reperfusão+1
  9. 2020

    Cannabidiol and Sports Performance: a Narrative Review of Relevant Evidence and Recommendations for Future Research

    FavorávelMetanáliseDorInflamaçãoAnsiedade+7
  10. 2020

    Cannabidiol and Vitamin D3 Impact on Osteogenic Differentiation of Human Dental Mesenchymal Stem Cells

    FavorávelEstudo LaboratorialOsteoporoseCáriesVitamina D
  11. 2020

    Cannabidiol anticonvulsant effect is mediated by the PI3Kγ pathway

    FavorávelEstudo em AnimaisEpilepsia
  12. 2020

    Cannabidiol as a Treatment for Mood Disorders: A Systematic Review

    InconclusivoMetanáliseAnsiedadeDepressãoTranstorno Bipolar
  13. 2020

    Cannabidiol as a treatment option for schizophrenia: recent evidence and current studies

    FavorávelMetanáliseEsquizofrenia
  14. 2020

    Cannabidiol attenuates behavioral changes in a rodent model of schizophrenia through 5-HT1A, but not CB1 and CB2 receptors

    FavorávelEstudo em AnimaisEsquizofrenia
  15. 2020

    Cannabidiol attenuates methamphetamine-induced conditioned place preference via the Sigma1R/AKT/GSK-3β/CREB signaling pathway in rats

    FavorávelEstudo em AnimaisDependência QuímicaDependência — Estimulantes
  16. 2020

    Cannabidiol disrupts conditioned fear expression and cannabidiolic acid reduces trauma-induced anxiety-related behaviour in mice

    FavorávelEstudo em AnimaisDorAnsiedadeEpilepsiaÁcido Canabidiólico (CBD-a)+1
  17. 2020

    Cannabidiol Drugs Clinical Trial Outcomes and Adverse Effects

  18. 2020

    Cannabidiol efficacy independent of clobazam: Meta-analysis of four randomized controlled trials

  19. 2020

    Cannabidiol enhances cytotoxicity of anti-cancer drugs in human head and neck squamous cell carcinoma

    FavorávelEstudo em AnimaisCâncerCâncer — Escamoso de Cabeça e Pescoço
  20. 2020

    Cannabidiol exerts protective effects in an in vitro model of Parkinson's disease activating AKT/mTOR pathway

    FavorávelEstudo LaboratorialDoença de Parkinson
  21. 2020

    Cannabidiol for epilepsy (Lennox-Gastaut syndrome, Dravet syndrome)

  22. 2020

    Cannabidiol for Pain Treatment: Focus on Pharmacology and Mechanism of Action

    FavorávelMetanáliseInflamaçãoArtriteArtrite — Osteoartrite
  23. 2020

    Cannabidiol for the treatment of cannabis use disorder: a phase 2a, double-blind, placebo-controlled, randomised, adaptive Bayesian trial

    FavorávelEnsaio Clínico Duplo-CegoDependência QuímicaDependência — Cannabis
  24. 2020

    Cannabidiol for the Treatment of Neonatal Hypoxic-Ischemic Brain Injury

    FavorávelMetanáliseInflamaçãoEstresse OxidativoAVC+2
  25. 2020

    Cannabidiol for Viral Diseases: Hype or Hope?

    InconclusivoMetanáliseHIV/AIDSHepatiteEncefalite e Mielite+5
  26. 2020

    Cannabidiol in cancer treatment

    FavorávelMetanáliseDorCâncerDor — Oncológica
  27. 2020

    Cannabidiol in Parkinson’s disease

    InconclusivoMetanáliseDoença de Parkinson
  28. 2020

    Cannabidiol increases the nociceptive threshold in a preclinical model of Parkinson's disease

    FavorávelEstudo em AnimaisDoença de ParkinsonAnandamida (AEA)
  29. 2020

    Cannabidiol induces antioxidant pathways in keratinocytes by targeting BACH1

    FavorávelEstudo em AnimaisDermatite de Contato AlérgicaPsoríaseEczema+1
  30. 2020

    Cannabidiol induces antioxidant pathways in keratinocytes by targeting BACH1

    FavorávelEstudo em AnimaisDoenças de Pele
  31. 2020

    Cannabidiol inhibits febrile seizure by modulating AMPA receptor kinetics through its interaction with the N-terminal domain of GluA1/GluA2

    FavorávelEstudo em AnimaisEpilepsiaEpilepsia — FIRES
  32. 2020

    Cannabidiol is an effective helper compound in combination with bacitracin to kill Gram-positive bacteria

    FavorávelEstudo LaboratorialInfecções BacterianasInfecção por Estafilococos
  33. 2020

    Cannabidiol Modulates Cytokine Storm in Acute Respiratory Distress Syndrome Induced by Simulated Viral Infection Using Synthetic RNA

    FavorávelEstudo em AnimaisCOVID-19
  34. 2020

    Cannabidiol normalizes resting-state functional connectivity in treatment-resistant epilepsy

    FavorávelEnsaio ClínicoEpilepsiaCBD Farmacêutico
  35. 2020

    Cannabidiol Oil-Associated Microscopic Colitis

  36. 2020

    Cannabidiol or CBD Oil: Help, Hope, and Hype for Psychiatric and Neurologic Conditions

    FavorávelMetanáliseEpilepsiaTetraidrocanabinol (THC)
  37. 2020

    Cannabidiol treatment in an adolescent with multiple substance abuse, social anxiety and depression

  38. 2020

    Cannabidiol: A Brief Review of Its Therapeutic and Pharmacologic Efficacy in the Management of Joint Disease

    FavorávelMetanáliseDorDor — CrônicaDor — Aguda+2
  39. 2020

    Cannabidiol: A Potential New Alternative for the Treatment of Anxiety, Depression, and Psychotic Disorders

    FavorávelMetanáliseAnsiedadeDepressãoPsicose
  40. 2020

    Cannabinoid and Terpenoid Doses are Associated with Adult ADHD Status of Medical Cannabis Patients

    FavorávelMetanáliseTDA e TDAHCanabinol (CBN)
  41. 2020

    Cannabinoid as Potential Aromatase Inhibitor Through Molecular Modeling and Screening for Anti-Cancer Activity

    FavorávelEstudo LaboratorialCâncerCâncer — MamaCanabitriol (CBT)
  42. 2020

    Cannabinoid Augmentation of Exposure-Based Psychotherapy for Obsessive-Compulsive Disorder

    FavorávelEnsaio ClínicoTOCEndocanabinoide (não especificado)THC Farmacêutico
  43. 2020

    Cannabinoid CB2 Receptor Functional Variation (Q63R) Is Associated with Multiple Sclerosis in Iranian Subjects

    FavorávelMetanáliseEsclerose Múltipla
  44. 2020

    Cannabinoid Combination Induces Cytoplasmic Vacuolation in MCF-7 Breast Cancer Cells

    FavorávelEstudo LaboratorialCâncerCâncer — MamaTetraidrocanabinol (THC)Canabigerol (CBG)+1
  45. 2020

    Cannabinoid hyperemesis syndrome in the pregnant patient: clinical case and literature review

    DesfavorávelMetanáliseSíndrome da Hiperêmese Canabinoide
  46. 2020

    Cannabinoid hyperemesis syndrome in two French emergency departments: a prospective cohort

    DesfavorávelMetanáliseSíndrome da Hiperêmese Canabinoide
  47. 2020

    Cannabinoid Hyperemesis Syndrome: A Case Report and Discussion Regarding Patients with Concurrent Disorders

    DesfavorávelMetanáliseDorEfeitos Adversos da CannabisDepressão+10
  48. 2020

    Cannabinoid Hyperemesis Syndrome: A Case Report of an Underdiagnosed Condition

    DesfavorávelMetanáliseDorEfeitos Adversos da CannabisNáusea e Vômito+1
  49. 2020

    Cannabinoid Hyperemesis Syndrome: A Review of Potential Mechanisms

    DesfavorávelMetanáliseSíndrome da Hiperêmese Canabinoide
  50. 2020

    Cannabinoid Hyperemesis Syndrome: An Unexpected Problem in an Unusual Setting-A Case Report

    DesfavorávelMetanáliseSíndrome da Hiperêmese Canabinoide
  51. 2020

    Cannabinoid hyperemesis syndrome: definition, pathophysiology, clinical spectrum, insights into acute and long-term management

    DesfavorávelMetanáliseSíndrome da Hiperêmese Canabinoide
  52. 2020

    Cannabinoid modulation of corticolimbic activation to threat in trauma-exposed adults: a preliminary study

    FavorávelEnsaio Clínico Duplo-CegoAnsiedadeTEPTEndocanabinoide (não especificado)THC Farmacêutico
  53. 2020

    Cannabinoid Receptor 2 Modulates Maturation of Dendritic Cells and Their Capacity to Induce Hapten-Induced Contact Hypersensitivity

    FavorávelEstudo em AnimaisDermatite de Contato Alérgica
  54. 2020

    Cannabinoid receptor activation on hematopoietic cells and enterocytes protects against colitis

    FavorávelEstudo em AnimaisDII — Doença Inflamatória Intestinal
  55. 2020

    Cannabinoid receptor expression in non-small cell lung cancer. Effectiveness of tetrahydrocannabinol and cannabidiol inhibiting cell proliferation and epithelial-mesenchymal transition in vitro

    FavorávelEstudo LaboratorialCâncerCâncer — Pulmão
  56. 2020

    Cannabinoid Receptor Type 2: A Possible Target in SARS-CoV-2 (CoV-19) Infection?

    FavorávelMetanáliseCOVID-19
  57. 2020

    Cannabinoid Receptors and Their Relationship With Chronic Pain: A Narrative Review

    FavorávelMetanáliseDorInflamaçãoDor — Crônica+2
  58. 2020

    Cannabinoid Signaling in Glioma Cells

  59. 2020

    Cannabinoid therapies in the management of sleep disorders: A systematic review of preclinical and clinical studies

    InconclusivoMetanáliseInsônia e Distúrbios do Sono
  60. 2020

    Cannabinoid Type 2 Receptor Agonist JWH133 Decreases Blood Pressure of Spontaneously Hypertensive Rats Through Relieving Inflammation in the Rostral Ventrolateral Medulla of the Brain

  61. 2020

    Cannabinoid-profiled agents improve cell survival via reduction of oxidative stress and inflammation, and Nrf2 activation in a toxic model combining hyperglycemia+Aβ 1-42 peptide in rat hippocampal neurons

    FavorávelEstudo LaboratorialDoença de AlzheimerAnandamida (AEA)2-Araquidonoilglicerol (2-AG)+3
  62. 2020

    Cannabinoid, Terpene, and Heavy Metal Analysis of 29 Over-the-Counter Commercial Veterinary Hemp Supplements

    InconclusivoMetanáliseAplicações Veterinárias
  63. 2020

    Cannabinoids and Cannabinoid Receptors: The Story so Far

    InconclusivoMetanáliseAnandamida (AEA)2-Araquidonoilglicerol (2-AG)+6
  64. 2020

    Cannabinoids and Chronic Liver Diseases

  65. 2020

    Cannabinoids and dystonia: an issue yet to be defined

    FavorávelMetanáliseDistonia
  66. 2020

    Cannabinoids and Hormone Receptor-Positive Breast Cancer Treatment

    FavorávelMetanáliseCâncerCâncer — MamaAnandamida (AEA)
  67. 2020

    Cannabinoids and Prostate Cancer: A Systematic Review of Animal Studies

    FavorávelMetanáliseCâncerCâncer — PróstataCanabinoides Sintéticos WIN-x
  68. 2020

    Cannabinoids and the Coronavirus

    InconclusivoMetanáliseCOVID-19
  69. 2020

    Cannabinoids and the Microbiota-Gut-Brain Axis: Emerging Effects of Cannabidiol and Potential Applications to Alcohol Use Disorders

    FavorávelMetanáliseDependência QuímicaDependência — ÁlcoolMicrobioma
  70. 2020

    Cannabinoids as an Emerging Therapy for Posttraumatic Stress Disorder and Substance Use Disorders

    FavorávelMetanáliseTEPT
  71. 2020

    Cannabinoids CB2 Receptors, One New Promising Drug Target for Chronic and Degenerative Pain Conditions in Equine Veterinary Patients

  72. 2020

    Cannabinoids for Pain Control During Medical Abortion: A Randomized Controlled Trial

    DesfavorávelEnsaio Clínico Duplo-CegoDorAnsiedadeNáusea e VômitoTHC Farmacêutico+2
  73. 2020

    Cannabinoids for People with ASD: A Systematic Review of Published and Ongoing Studies

    FavorávelMetanáliseAutismoTHC FarmacêuticoTHC:CBD Farmacêutico+1
  74. 2020

    Cannabinoids for the Neuropsychiatric Symptoms of Dementia: A Systematic Review and Meta-Analysis

    FavorávelMetanáliseDisfunção CognitivaDemência
  75. 2020

    Cannabinoids for the treatment of chronic pruritus: A review

    FavorávelMetanálisePrurido
  76. 2020

    Cannabinoids in Chronic Non-Cancer Pain: A Systematic Review and Meta-Analysis

    FavorávelMetanáliseDorDor — Crônica
  77. 2020

    Cannabinoids in Dermatology: Hope or Hype?

    FavorávelMetanáliseInflamaçãoDoenças de PeleAcne+3
  78. 2020

    Cannabinoids in multiple sclerosis: A neurophysiological analysis

    FavorávelEnsaio ClínicoEsclerose MúltiplaTHC:CBD Farmacêutico
  79. 2020

    Cannabinoids in the Management of Acute Pain: A Systematic Review and Meta-analysis

    FavorávelMetanáliseDorDor — Aguda
  80. 2020

    Cannabinoids in the Pathophysiology of Skin Inflammation

    FavorávelMetanáliseCâncerInflamaçãoDoenças de Pele+2
  81. 2020

    Cannabinoids in the Treatment of Back Pain

    FavorávelMetanáliseDorDor — CrônicaDependência — Opioides
  82. 2020

    Cannabinoids in the Treatment of Epilepsy: Current Status and Future Prospects

    FavorávelMetanáliseEpilepsia
  83. 2020

    Cannabinoids in the Treatment of Insomnia Disorder: A Systematic Review and Meta-Analysis

    FavorávelMetanálise ClínicaInsônia e Distúrbios do Sono
  84. 2020

    Cannabinoids Promote Progression of HPV-Positive Head and Neck Squamous Cell Carcinoma via p38 MAPK Activation

  85. 2020

    Cannabinoids Rescue Cocaine-Induced Seizures by Restoring Brain Glycine Receptor Dysfunction

    FavorávelEstudo em AnimaisDependência QuímicaEpilepsiaDependência — Cocaína
  86. 2020

    Cannabinoids use in adolescents and young adults with cancer: a single-center survey

    FavorávelMetanáliseDorCâncerAnsiedade+2
  87. 2020

    Cannabinoids-Promising Antimicrobial Drugs orIntoxicants with Benefits?

    FavorávelMetanáliseInfecção por Estafilococos
  88. 2020

    Cannabinoids, Endocannabinoids and Sleep

  89. 2020

    Cannabinoids, Inner Ear, Hearing, and Tinnitus: A Neuroimmunological Perspective

    FavorávelMetanáliseZumbido
  90. 2020

    Cannabinoids: A New Perspective on Epileptogenesis and Seizure Treatment in Early Life in Basic and Clinical Studies

    FavorávelMetanáliseEpilepsia
  91. 2020

    Cannabinol in the spotlight: Toxicometabolomic study and behavioral analysis of zebrafish embryos exposed to the unknown cannabinoid

  92. 2020

    Cannabis allergy in a child with asthma chronically exposed to marijuana

    DesfavorávelMetanáliseAlergia à Cannabis
  93. 2020

    Cannabis and Canabidinoids on the Inflammatory Bowel Diseases: Going Beyond Misuse

  94. 2020

    Cannabis and Cognition: Connecting the Dots towards the Understanding of the Relationship

    DesfavorávelMetanáliseDisfunção CognitivaCanabinoide Sintético (não especificado)
  95. 2020

    Cannabis and Inflammatory Mediators

    DesfavorávelMetanáliseInflamaçãoEfeitos Adversos da CannabisEsclerose Múltipla
  96. 2020

    Cannabis and multiple sclerosis

    FavorávelMetanáliseEsclerose MúltiplaTHC:CBD Farmacêutico
  97. 2020

    Cannabis and Radiation Therapy: A Scoping Review of Human Clinical Trials

    FavorávelMetanáliseDependência QuímicaDependência — Cannabis
  98. 2020

    Cannabis and the Cornea

    FavorávelMetanáliseDorDor — OcularCatarata
  99. 2020

    Cannabis and Vulvodynia Symptoms: A Preliminary Report

    FavorávelMetanáliseDorDor — CrônicaMenopausa
  100. 2020

    Cannabis as entheogen: survey and interview data on the spiritual use of cannabis

    FavorávelMetanáliseMedicina Mente-Corpo